Bio-Techne
TECH
#1957
Rank
HK$77.06 B
Marketcap
HK$494.62
Share price
-0.44%
Change (1 day)
-15.91%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2025 (TTM): HK$3.88

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is HK$3.89. In 2024 the company made an earnings per share (EPS) of HK$7.78 a decrease over its 2023 EPS that were of HK$11.05.

EPS history for Bio-Techne from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$3.88-50.17%
2024HK$7.78-29.58%
2023HK$11.05-14.97%
2022HK$13.0024.16%
2021HK$10.4717.98%
2020HK$8.87-10.94%
2019HK$9.96101.57%
2018HK$4.94-16.99%
2017HK$5.9645.02%
2016HK$4.11-20.97%
2015HK$5.20-14.97%
2014HK$6.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
HK$134.98 3,368.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
-HK$189.24-4,962.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
HK$43.36 1,014.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
HK$37.99 876.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
HK$14.55 273.74%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
General Electric
GE
HK$58.85 1,412.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-HK$1.63-142.00%๐Ÿ‡บ๐Ÿ‡ธ USA